Authors
Mohammed K. Ali, Nikkil Sudharsanan & Harsha Thirumurthy
CHIBE Experts
Research Areas
You might also be interested in...
View all publications-
Measuring Quality-Weighted Hospital-Free-Days in Acute Respiratory Failure: A Modified Delphi Study
Annals of the American Thoracic SocietyMarch 20, 2024 -
Philadelphia Beverage Tax's Impact on Beverage Ad Expenditures and Number of Ads Purchased
American Journal of Preventive MedicineMarch 18, 2024 -
Field Testing the Transferability of Behavioural Science Knowledge on Promoting Vaccinations
Nature Human BehaviourMarch 14, 2024 -
Impact of the Philadelphia Beverage Tax on Perceived Beverage Healthfulness, Tax Awareness, and Tax Opinions
Journal of Nutrition Education and BehaviorMarch 9, 2024 -
The Next Decade of Healthcare
HealthcareFebruary 29, 2024 -
Health Care Resource Utilization and Costs Associated With Diagnosed Medication Overuse Headache and Potential Acute Medication Overuse in Individuals With Migraine
CephalalgiaFebruary 27, 2024 -
Evaluating the Implementation of a Community Health Worker-Delivered Intervention Integrating Asthma Care in West Philadelphia Public Schools
Journal of AsthmaFebruary 9, 2024 -
Real-World Survival, Healthcare Resource Utilization, and Costs Among U.S. Elderly Patients With Diffuse Large B-Cell Lymphoma (DLBCL) Treated With R-GemOx in the Relapsed/Refractory Setting
Clinical Lymphoma Myeloma LeukemiaFebruary 8, 2024 -
A Social Network Analysis of Hemodialysis Clinics: Attitudes Towards Living Donor Kidney Transplant Among Influential Patients
Kidney360February 7, 2024 -
Are Caregivers' Feeding Competence and Autonomy Associated with Healthier Restaurant Food Purchases for Their Child at Fast Food or Counter Service Restaurants? A Cross-Sectional Study in a Diverse Sample of U.S. Caregivers
NutrientsFebruary 7, 2024 -
Officer-Involved Killings of Unarmed Black People and Racial Disparities in Sleep Health
JAMA Internal MedicineFebruary 5, 2024 -
Real-World Analysis of Adverse Event Rates After Initiation of Ibrutinib Among Medicare Beneficiaries With Chronic Lymphocytic Leukemia
Cancer MedicineFebruary 1, 2024